Pioneering Pharmaceuticals
Making pharmaceuticals more affordable, more available, and better than before
Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register innovative as well as generic drugs for our B2B customers. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites empower us to build up efficient supply chains resulting in best value for money for our customers.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.
Driving force for advanced medicines
The numbers speak for us
>500million
patients served every year
600+
employees worldwide
180+
dossiers developed/ under development
40+
projects in pipeline
>500million
patients served every year
~600
employees worldwide
100+
dossiers developed
40+
development projects running
>3billion
units inhouse production capacity per year
15.000+
marketing authorizations obtained
80+
different countries where products are being sold
150+
active customers on five continents
~3bn
units production capacity per year
15.000+
marketing authorizations obtained
80+
different countries where products are being sold
150+
active customers on five continents
AET: Specialized in the Development and Commercialization of pharmaceuticals
Our purpose - Care for patients´ health by offering:
We are TIEFENBACHER GROUP
News
New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP
Swedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation…
Spreading of Post COVID-19 Disease „Black Fungus“ in India – TIEFENBACHER GROUP supports with Posaconazole Tablets
Black Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The highly life-threatening disease usually occurs as a rare disease in immunocompromised…
GLOBAL PRESENCE AROUND THE WORLD
Our path to profitable growth: Creating breakthrough pharmaceuticals worldwide I more affordable, more available, and better than before
Contact – Partner with us
As the builders of the future, we´re working to improve patients´ lives. By thinking beyond healthcare.
ALFRED E. TIEFENBACHER (GmbH & Co. KG)
Van-der-Smissen-Strasse 1
22767 Hamburg
Germany
Phone: +49 40 – 44 18 09 – 0
Fax: +49 40 – 44 18 09 – 26
Mail: info@aet.eu
